This is the authors' abstract. We don't add key points for this paper.
Purpose: Intraoperative risk-stratification models for acute kidney injury (AKI) in older patients undergoing major abdominal surgery remain limited. This study primarily aimed to develop and temporally validate an intraoperative risk-stratification model for this population, and secondarily to explore the potential association between intraoperative dexmedetomidine use and AKI risk. Methods: A prospective multicenter observational study with a training set (11 Chinese centers, June 19, 2022 to December 25, 2023, n = 1,375) and a single-center prospective validation set (January 2024 to August 2025, n = 300) were analyzed. Eligible patients were older patients (65 years old or older) undergoing major non-vascular abdominal surgery, with no pre-existing kidney disease and normal baseline renal function (normal serum creatinine and estimated glomerular filtration rate ≥ 60 mL/min/1.73 m 2 ). Predictors were selected by LASSO regression across 25 imputed datasets using repeated cross-validation. Dexmedetomidine was added post hoc in an augmented model based on prior evidence suggesting a potential renoprotective effect. Validation included bootstrap repetition, leave-one-center-out cross-validation, and the temporal validation set. Results: Postoperative AKI occurred in 81 patients (5.9%) in the training set and 17 patients (5.7%) in the validation set. LASSO retained four predictors, including history of heart failure, prolonged severe hypotension, intraoperative erythrocyte transfusion, and large blood loss. The optimism-corrected area under the curve (AUC) was 0.71 and the calibration slope was 0.91. In the augmented model, dexmedetomidine had an odds ratio of 0.44, which attenuated to 0.51 after overlap weighting, and improved the corrected AUC to 0.74. In temporal validation, the AUC was 0.78 (95% CI, 0.65– 0.90) and the calibration slope was 1.12. Conclusions: A four-variable intraoperative risk-stratification model was developed for older patients undergoing major abdominal surgery, demonstrating moderate discrimination and calibration. The dexmedetomidine association is hypothesis-generating and requires randomized confirmation. Limited temporal validation events warrant cautious interpretation, and independent multicenter validation is required prior to clinical implementation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: